enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    The best-selling drugs list published by Genetic Engineering & Biotechnology News, shows that Humira occupied the #1 position for 2015 (US$14.012 billion) and 2016 (US$16.078 billion) [99] From 2012 until the US patent expired in 2016, Humira led the list of top-selling pharmaceutical products, and in 2016, it had US$16 billion of global sales ...

  3. PDF - Wikipedia

    en.wikipedia.org/wiki/PDF

    The PDF 1.4 specification allowed form submissions in XML format, but this was replaced by submissions in XFDF format in the PDF 1.5 specification. XFDF conforms to the XML standard. XFDF can be used in the same way as FDF; e.g., form data is submitted to a server, modifications are made, then sent back and the new form data is imported in an ...

  4. TNF inhibitor - Wikipedia

    en.wikipedia.org/wiki/TNF_inhibitor

    A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...

  5. UnitedHealth to remove AbbVie's Humira from some US drug ...

    www.aol.com/news/unitedhealth-remove-abbvies...

    The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.

  6. AbbVie to buy cancer drugmaker ImmunoGen for $10 billion as ...

    www.aol.com/news/abbvie-signs-10-1-billion...

    (Reuters) -AbbVie will buy ImmunoGen for $10.1 billion in cash, it said on Thursday, the latest major drugmaker to buy a developer of 'guided missile' cancer therapies as the company's top-seller ...

  7. Biologics license application - Wikipedia

    en.wikipedia.org/wiki/Biologics_License_Application

    A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.

  8. New Drug Application - Wikipedia

    en.wikipedia.org/wiki/New_Drug_Application

    The results of the testing program are codified in an FDA-approved public document that is called the product label, package insert or Full Prescribing Information. [10] The prescribing information is widely available on the web from the FDA, [11] drug manufacturers, and frequently inserted into drug packages. The main purpose of a drug label ...

  9. Dosage form - Wikipedia

    en.wikipedia.org/wiki/Dosage_form

    The term dosage form may also sometimes refer only to the pharmaceutical formulation of a drug product's constituent substances, without considering its final configuration as a consumable product (e.g., capsule, patch, etc.). Due to the somewhat ambiguous nature and overlap of these terms within the pharmaceutical industry, caution is ...